Canada markets closed
  • S&P/TSX

    -487.28 (-2.25%)
  • S&P 500

    -106.84 (-2.27%)
  • DOW

    -905.04 (-2.53%)

    -0.0085 (-1.07%)

    -10.24 (-13.06%)

    -5,293.35 (-7.07%)
  • CMC Crypto 200

    -89.82 (-6.17%)

    +1.20 (+0.07%)
  • RUSSELL 2000

    -85.52 (-3.67%)
  • 10-Yr Bond

    -0.1630 (-9.91%)

    -353.57 (-2.23%)

    +10.04 (+54.04%)
  • FTSE

    -266.34 (-3.64%)
  • NIKKEI 225

    -747.66 (-2.53%)

    -0.0143 (-2.03%)

Feinstein Institutes’ Haichao Wang Recognized by Shock Society for Sepsis Research

·3 min read

MANHASSET, N.Y., October 18, 2021--(BUSINESS WIRE)--Haichao Wang, PhD, one of The Feinstein Institutes for Medical Research’s leading inflammation and sepsis researchers, has earned the Shock Society’s 2021 Scientific Achievement Award for his years of commitment toward sepsis research and significant contributions to the Society. The award was presented virtually to Dr. Wang at the 2021 Shock Society 44th Annual Meeting on October 15, 2021.

This press release features multimedia. View the full release here:

Haichao Wang, PhD has been awarded the Shock Society’s 2021 Scientific Achievement Award. (Credit: Feinstein Institutes)

"It is a great honor to be recognized by the Shock Society with this award and I am particularly grateful to my contemporaries across the globe for their nomination," said Dr. Wang, professor in the Institute of Molecular Medicine at the Feinstein Institutes. "Together, with the intersection of basic science and clinical research, we will strive to find novel and effective therapies to help prevent and treat sepsis."

Sepsis is a life-threatening syndrome caused by a dysregulated host response to lethal infections. Dr. Wang’s research focuses on improving our understanding of the intricate molecular mechanisms that regulate the body’s immune system and inflammation, particularly through the search for proteins that control sepsis.

"Dr. Wang is a leader and pioneer in inflammation and sepsis research," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes. "His recognition by the Shock Society is a fitting tribute for his outstanding career."

Dr. Wang and his lab are looking at novel therapeutic strategies – including the use of neutralizing antibodies and anti-inflammatory medicinal herbs -- for the clinical management of human inflammatory diseases.

Recently, Dr. Wang published an article in the journal Science Translational Medicine, which explored a new antibody strategy to target other less harmful proteins capable of modulating dysregulated inflammation and lethal sepsis. In a review article recently published in the journal Cells, Dr. Wang summarized his significant contributions to the research in trauma, shock, and sepsis by citing his 60 major publications. Since 1995, Dr. Wang has published more than 190 research and review articles that have been collectively cited 46,670 times by the Google Scholar.

The Shock Society was founded in 1978 to foster the integration of basic and clinical research to understand the pathogenesis of trauma, sepsis and shock, and to develop new therapeutic approaches. Since 1997, the Scientific Achievement Award was established to honor an individual who has made significant contributions to the broad field of shock research. Nominations for the award are solicited annually from the membership, and an awardee is selected by the Society’s Awards & Honors committee.

In 2020, Ping Wang, MD, the Feinstein Institutes’ chief scientific officer, was also awarded Scientific Achievement Award by the Shock Society, as was Dr. Tracey in 2016, signifying the institutional strength in relevant research fields.

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit and follow us on LinkedIn.

View source version on


Matthew Libassi

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting